Retrospective study of efficacy and tolerability of liposomal irinotecan plus 5fu/lv in the treatment of pancreatic adenocarcinoma.
REST OF EEOO WITH MEDICATIONS
Clinical trial information
- Promoter: HM HOSPITALES RESEARCH FOUNDATION
- Execution start: 24/05/2022
- End of execution: 30/08/2022
- PI: JOAQUINA MARTINEZ GALAN